1-10 of 10
Rebecca L Porter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intermittent in Vivo Parathyroid Hormone (PTH) Treatment Results in Jagged 1 (Jag 1) Dependent and Independent Effects On Hematopoietic Stem Cells (HSCs)

Benjamin J Frisch, Ph.D., Ismat Shafiq, M.D., Rebecca L Porter, Ph.D., Jonathan M Weber, Ph.D., MBA, Julianne N Smith, M.S., Olga Bromberg, Miles Basil, Robinder S Dhillon, M.D., Edward M Schwarz, Ph.D., Laura M Calvi, M.D.
Journal: Blood
Blood (2012) 120 (21): 642.
https://doi.org/10.1182/blood.V120.21.642.642
Published: 2012
Journal Articles

Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells

Olga Bromberg, Benjamin J. Frisch, Jonathan M. Weber, Rebecca L. Porter, Roberto Civitelli, Laura M. Calvi
Journal: Blood
Blood (2012) 120 (2): 303–313.
https://doi.org/10.1182/blood-2011-09-377853
Published: 2012
Includes: Supplemental data
Journal Articles

Prostaglandin E2 Inhibits Apoptosis in Hematopoietic Stem and Progenitor Cells and Enhances Their Survival Following Sub-Lethal Radiation Injury,

Rebecca L Porter, PhD, Mary A Georger, Laura M Calvi, M.D.
Journal: Blood
Blood (2011) 118 (21): 3401.
https://doi.org/10.1182/blood.V118.21.3401.3401
Published: 2011
Journal Articles

Prostaglandin E2 Is Rapidly Produced In Response to Bone Marrow Injury and Improves Survival of Primitive Hematopoietic Cells

Rebecca L Porter, M.S., Laura M Calvi, M.D.
Journal: Blood
Blood (2010) 116 (21): 407.
https://doi.org/10.1182/blood.V116.21.407.407
Published: 2010
Journal Articles

In Vivo Parathyroid Hormone Treatment Expands All Multipotent Primitive Hematopoietic Cell Subsets.

Jonathan M Weber, Benjamin J Frisch, Rebecca L Porter, Olga Bromberg, Adam J Olm-shipman, Hani Awad, Laura M Calvi, MD
Journal: Blood
Blood (2009) 114 (22): 1449.
https://doi.org/10.1182/blood.V114.22.1449.1449
Published: 2009
Journal Articles

In vivo prostaglandin E 2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells

Benjamin J. Frisch, Rebecca L. Porter, Benjamin J. Gigliotti, Adam J. Olm-Shipman, Jonathan M. Weber, Regis J. O'Keefe, Craig T. Jordan, Laura M. Calvi
Journal: Blood
Blood (2009) 114 (19): 4054–4063.
https://doi.org/10.1182/blood-2009-03-205823
Published: 2009
Includes: Supplemental data
Journal Articles

Prostaglandin E2 (PGE2) Treatment Rapidly Increases the Fraction of Non-Dividing Hematopoietic Stem Cells (HSCs)

Rebecca L Porter, Benjamin J Frisch, Regis J O’Keefe, MD, PhD, Laura M Calvi, MD
Journal: Blood
Blood (2008) 112 (11): 73.
https://doi.org/10.1182/blood.V112.11.73.73
Published: 2008
Journal Articles

Enucleation of primitive erythroid cells generates a transient population of “pyrenocytes” in the mammalian fetus

Kathleen E. McGrath, Paul D. Kingsley, Anne D. Koniski, Rebecca L. Porter, Timothy P. Bushnell, James Palis
Journal: Blood
Blood (2008) 111 (4): 2409–2417.
https://doi.org/10.1182/blood-2007-08-107581
Published: 2008
Includes: Supplemental data
Journal Articles

Enucleation of Primitive Erythroid Cells Generates a Transient Population of “Pyrenocytes” in the Mammalian Fetus.

Kathleen E. McGrath, Paul D. Kingsley, Anne Koniski, Rebecca L. Porter, Timothy P. Bushnell, James Palis
Journal: Blood
Blood (2007) 110 (11): 425.
https://doi.org/10.1182/blood.V110.11.425.425
Published: 2007
Journal Articles

In Vivo Treatment with Prostaglandin E 2 (PGE2) Selectively Expands Short-Term Hematopoietic Stem Cells.

Benjamin J. Frisch, BS, Jonathan M. Weber, B.S., Rebecca L. Porter, B.S., Benjamin J. Gigliotti, B.S., Julianne N. Smith, Adam J. Olm-Shipman, B.S., Regis J. O’Keefe, M.D., PhD, Craig T. Jordan, PhD, Laura M. Calvi, M.D.
Journal: Blood
Blood (2007) 110 (11): 1254.
https://doi.org/10.1182/blood.V110.11.1254.1254
Published: 2007